ClinicalTrials.Veeva

Menu

Study of the Short-term Mortality and Morbidity of Newborns Born at a Gestational Age <32 Weeks of Amenorrhea (OutBorn)

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Premature Birth

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

An "outborn" birth is a premature birth that occurs in an unsuitable level center at the end of the child (unlike "inborn" births).

This study aims to describe the morbidity and mortality of very premature newborns (gestational age less than 32 weeks of amenorrhea) born outside a maternity hospital of appropriate level between January 1, 2016 and December 31, 2020, and assessment of the preventable or non-preventable nature of these so-called "outborn" births.

The aim of this research is to write down the short-term mortality and morbidity of newborns born at a gestational age <32 weeks of amenorrhea outside a level III maternity hospital in Alsace between January 1, 2016 and December 31, 2020.

Enrollment

134 estimated patients

Sex

All

Ages

32+ weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Newborn under 32 weeks of amenorrhea at the time of birth, born in Alsace in one of the level I, IIa, or IIb maternity hospitals, between January 1, 2016 and December 31, 2020

Exclusion criteria

  • Fetal death in utero

Trial contacts and locations

1

Loading...

Central trial contact

Benoit ESCANDE, MD; Saïd CHAYER, PhD, HDR

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems